Intensity Therapeutics Ownership | Who Owns Intensity Therapeutics?

Intensity Therapeutics Ownership Summary

Intensity Therapeutics is owned by 0.56% institutional investors, 4.56% insiders, and 94.89% retail investors. Vanguard group is the largest institutional shareholder, holding 3.44% of INTS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.44% of its assets in Intensity Therapeutics shares.

INTS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Intensity Therapeutics	0.56%	4.56%	94.89%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	649.08K	3.44%	$266.13K
Scientech research	24.73K	0.13%	$6.00K
Cibc private wealth group	5.03K	0.03%	$2.06K
Sassicaia capital advisers	-	-	-
Two sigma securities	-	-	-
Sentinus	-	-	-
Tower research capital llc (trc)	-	-	-
Jane street group	-	-	-
Boothbay fund management	-	-	-
Vontobel	-	-	-

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Scientech research	24.73K	0.00%	$6.00K
Sassicaia capital advisers	-	-	-
Vontobel	-	-	-
Tower research capital llc (trc)	-	-	-
Two sigma securities	-	-	-
Sentinus	-	-	-
Sigma planning	-	-	-
Jane street group	-	-	-
Boothbay fund management	-	-	-
Geode capital management	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Vanguard group	649.08K	-	393.15K
Scientech research	24.73K	0.00%	24.73K
Cibc private wealth group	5.03K	-	25.00
Jpmorgan chase	-	-	-15.00
Citigroup	-	-	-88.00

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-872.55K
Sapient capital	-	-	-650.15K
Sentinus	-	-	-495.91K
Geode capital management	-	-	-460.25K
Mesirow financial investment management	-	-	-251.00K

New Positions

Holder	Shares	% Assets	Change	Value
Scientech research	24.73K	0.00%	24.73K	$6.00K

Sold Out

Holder	Change
Jpmorgan chase	-15.00
Citigroup	-88.00
Fmr	-100.00
Morgan stanley	-500.00
Pensionmark financial group	-10.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	12	-65.71%	141,078	-96.40%	-	0.13%	5	-79.17%	7	-12.50%
Dec 31, 2025	24	-7.69%	3,378,788	14.09%	17	7.27%	15	-	6	500.00%
Sep 30, 2025	25	-7.41%	2,956,433	49.41%	15	14.25%	15	-11.76%	1	-50.00%
Jun 30, 2025	27	28.57%	1,978,698	-23.56%	10	3.60%	17	54.55%	2	-50.00%
Mar 31, 2025	21	5.00%	2,588,459	-4.84%	17	4.46%	11	57.14%	4	-20.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	265.38K	1.44%	-
Vanguard Institutional Extnd Mkt Idx Tr	16.84K	0.66%	-
Fidelity Extended Market Index	14.76K	0.56%	3.79K
Fidelity Series Total Market Index	3.25K	0.12%	641.00
Spartan Extended Market Index Pool F	3.12K	0.12%	3.01K
Fidelity Total Market Index	3.09K	0.12%	-
Northern Trust Extended Eq Market Idx	2.71K	0.11%	2.40K
NT Ext Equity Mkt Idx Fd - L	2.71K	0.11%	-
NT Ext Equity Mkt Index Fund - Lending	2.71K	0.11%	-
iShares Micro-Cap ETF	18.04K	0.10%	-

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2024 Q4	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	-	-

INTS Ownership FAQ

Who Owns Intensity Therapeutics?

Intensity Therapeutics shareholders are primarily institutional investors at 0.56%, followed by 4.56% insiders and 94.88% retail investors. The average institutional ownership in Intensity Therapeutics's industry, Biotech Stocks , is 35.75%, which Intensity Therapeutics falls below.

Who owns the most shares of Intensity Therapeutics?

Intensity Therapeutics’s largest shareholders are Vanguard group (649.08K shares, 3.44%), Scientech research (24.73K shares, 0.13%), and Cibc private wealth group (5.02K shares, 0.03%). Together, they hold 3.60% of Intensity Therapeutics’s total shares outstanding.

Does Blackrock own Intensity Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Intensity Therapeutics.

Who is Intensity Therapeutics’s biggest shareholder by percentage of total assets invested?

Scientech research is Intensity Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 24.73K Intensity Therapeutics shares, valued at 6K$.

Who is the top mutual fund holder of Intensity Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Intensity Therapeutics shares, with 1.44% of its total shares outstanding invested in 265.38K Intensity Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools